Qube Research & Technologies Ltd - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 165 filers reported holding CARA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,552
-97.7%
3,305
-96.2%
0.00%
-100.0%
Q2 2023$245,551
+229.9%
86,767
+472.4%
0.00%
Q1 2023$74,431
-74.8%
15,159
-51.8%
0.00%
-100.0%
Q3 2022$295,000
-57.2%
31,466
-58.4%
0.00%
-60.0%
Q2 2022$690,000
+233.3%
75,609
+344.3%
0.01%
+150.0%
Q1 2022$207,00017,0180.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 3,193,057$51,440,00039.10%
Chescapmanager LLC 1,299,701$20,938,0003.08%
Burrage Capital Management LLC 284,170$4,578,0003.07%
Cypress Capital Management LLC (WY) 184,085$2,966,0002.80%
DAFNA Capital Management LLC 328,533$5,293,0001.82%
Mesirow Financial Investment Management, Inc. 21,169$341,0001.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 471,575$7,597,0001.14%
AdvisorShares Investments LLC 79,821$1,286,0000.80%
ETF MANAGERS GROUP, LLC 750,680$12,093,0000.42%
FARALLON CAPITAL MANAGEMENT LLC 2,300,000$37,053,0000.25%
View complete list of CARA THERAPEUTICS INC shareholders